Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America
Paola Martinez-Murillo(University of Geneva), Claire‐Anne Siegrist(University of Geneva), Arnaud M. Didierlaurent(University of Geneva), Ali M. Harandi(University of British Columbia), Sylvain Lemeille(University of Geneva), Tom H. M. Ottenhoff(Office of Infectious Diseases), Angela Huttner(University Hospital of Geneva), Donata Medaglini(University of Siena)
Cited by 3
Related Papers
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
|The Journal of Immunology|2009|739
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans
|Human Immunology|2004|413
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
|New England Journal of Medicine|2015|412
Diagnosis of Childhood Tuberculosis and Host RNA Expression in Africa
|New England Journal of Medicine|2014|392